# Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions

> **NCT00878514** · PHASE1 · COMPLETED · sponsor: **Orion Corporation, Orion Pharma** · enrollment: 18 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Alprazolam
- **DRUG:** Xanax

## Key facts

- **NCT ID:** NCT00878514
- **Lead sponsor:** Orion Corporation, Orion Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-06
- **Final completion:** 2009-07
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2009-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878514, "Bioequivalence Study Comparing Two Alprazolam 1 mg Tablets Under Fed Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00878514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*